Cytec Industries Inc v Nalco Company

The case of Cytec Industries Inc v Nalco Company involved a dispute concerning the validity of patent claims related to compositions and methods for treating scale in industrial process streams, specifically within the Bayer process. The Federal Court of Australia was tasked with determining whether the patent claims met the statutory requirements under the Patents Act 1990 (Cth). The primary issue before the court was the clarity and enablement of certain patent claims, particularly those related to the composition of matter and methods of using them to treat scale in the Bayer process.

The court examined whether the claims were clear and whether the specification provided an enabling disclosure. The Opponent argued that claims 1-3, 14-22 lacked clarity and did not provide an enabling disclosure as required by section 40(2)(a) of the Patents Act. The court considered the arguments and evidence presented, including expert testimony and the content of the patent specification. The court determined that claims 1-3, 14-22 were not clear as they referred to an undefined variable "n" and included unspecified compounds such as carbamates, ureas, amides, and salts thereof. The court found that the specification did not provide sufficient information to enable the person skilled in the art to make and use the claimed compounds, particularly when used alone and in isolation.

Based on the findings, the court concluded that the claims were not clear and did not meet the statutory requirement of providing an enabling disclosure. The patent claims were thus found to be invalid. The court ordered that the patent be refused on the grounds that it did not meet the clarity and enablement requirements under section 40(2)(a) of the Patents Act.